Vertex Pharmaceuticals will soon try to commercialize another medicine. The new therapy targets the same market as four of its other products. Using a priority review voucher is an expensive choice, ...

Vertex Pharmaceuticals received FDA approval for expanded use of its cystic fibrosis therapies, increasing the number of ...

Under the agreement, Vertex will make a $15m upfront payment to Halozyme and potential future milestone payments.

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators said they didn’t see a path forward for broad use of its pill in treating a ...

Deal Values Each Alpine Share at a 38% Premium to Wednesday’s Closing Price Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Vertex shares ...

Total revenues of $666.8 million for the full year 2024, representing a 16.5% year-over-year increase, indicating strong business growth. Cloud revenues grew by 28.6% year-over-year for the full year ...

Halozyme Therapeutics (NASDAQ:HALO) said its subsidiary has entered into an exclusive collaboration and licensing agreement ...

Google announced today that its generative AI support in Vertex AI, the company’s machine learning platform, is now generally available. Based on Google’s models like PaLM 2, Imagen and Codey, Vertex ...

Switzerland-based CRISPR Therapeutics (CRSP) and Boston, Massachusetts-based Vertex (VRTX) have been collaborating together since signing an initial agreement in 2015, with Vertex paying CRISPR $75m ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Misconfigured AI agents can lead to data disclosure ...